Patient Guide: Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 279 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06745024
Status: 🟢 Enrolling Now
Condition: Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm
Phase: PHASE3

Where You Can Participate

This study is available at 279 locations across the country.

Top locations include:
  • • Fairbanks, Alaska
  • • Phoenix, Arizona
  • • Antioch, California
  • • And 276 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases - Join Clinical Trial NCTNCT06745024

How to Join This Clinical Trial - NCTNCT06745024

Learn how to participate in this PHASE3 trial studying an investigational therapy for Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06745024 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 279 locations. Find a study site near you:

Clinical Research Site

Fairbanks, Alaska 99701 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85004 - United States

Status: RECRUITING

Clinical Research Site

Antioch, California 94531 - United States

Status: RECRUITING

Clinical Research Site

Arroyo Grande, California 93420 - United States

Status: RECRUITING

Clinical Research Site

Auburn, California 95602 - United States

Status: RECRUITING

Clinical Research Site

Auburn, California 95603 - United States

Status: RECRUITING

Clinical Research Site

Bakersfield, California 93301 - United States

Status: RECRUITING

Clinical Research Site

Berkeley, California 94704 - United States

Status: RECRUITING

Clinical Research Site

Burlingame, California 94010 - United States

Status: RECRUITING

Clinical Research Site

Cameron Park, California 95682 - United States

Status: RECRUITING

And 269 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships